Skip to main content
Premium Trial:

Request an Annual Quote

MGI MGISEQ-T7, MGISP-960, stLFR Library Prep Kit, MegaBolt Somatic

MGI, a subsidiary of the BGI Group, has released the MGISEQ-T7 sequencing platform. The instrument can take up to four flow cells per run, which can be operated independently of each other. The platform, which supports whole-genome sequencing, deep exome sequencing, epigenetic sequencing, and panel sequencing, generates up to 6 terabases of data per day. A run with 150-base paired-end reads takes less than 24 hours, and one instrument can sequence up to 10,000 human genomes per year.

MGI also launched the MGISP-960, an automated sample preparation system that can prepare 96 samples per run. In addition, it said that a new library preparation kit for single-tube Long Fragment Read (stLFR) technology will be commercially available in December. Finally, the company announced MegaBolt Somatic, an extended application for tumor mutation detection based on the MegaBolt bioinformatics accelerator. For more on the new BGI sequencing platform, click here.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more